Advertisement

Topics

Ginkgo Bioworks Company Profile

14:32 EST 9th December 2018 | BioPortfolio

Ginkgo Bioworks is an organism design company that is building organisms to spec for customers across markets including nutrition, health and consumer goods. The company’s organism engineers work directly with customers including Fortune 500 companies to design microbes for their specific needs. The company was founded in 2008 by Tom Knight, a world-renowned computer scientist, as well as MIT engineering PhD graduates Jason Kelly, Reshma Shetty, Barry Canton and Austin Che. Ginkgo Bioworks is based in Boston and is financially backed by Felicis Ventures, OS Fund, Data Collective, Y Combinator, iGlobe Partners, and Vast Ventures as well as other angel investors and funds.


News Articles [25 Associated News Articles listed on BioPortfolio]

Ginkgo Bioworks and Glycosyn LLC Announce $14MM Deal to Scale Production of Human Milk Oligosaccharides

Ginkgo offers accessible synthetic biology infrastructure to realize untapped nutritional and pharmaceutical applications BOSTON, Nov. 8, 2018 /PRNewswire/ — Today, Ginkgo Bioworks, the organism...

Ginkgo Bioworks Opens Bioworks4, Adds New Tools for the Rapid Genetic Engineering of Mammalian Cells

Newest foundry catalyzes synthetic biology for pharmaceutical applications, empowering accessible and scalable R&D for therapeutics BOSTON, Oct. 24, 2018 /PRNewswire/ — Ginkgo Bioworks, the...

Ginkgo Bioworks Marks 10-Year Anniversary with iGEM Partnership

The post Ginkgo Bioworks Marks 10-Year Anniversary with iGEM Partnership appeared first on SynBioBeta.

With Cronos Deal, Ginkgo Brings Synthetic Bio Approach to Cannabis

In a partnership that gives new meaning to mixing pot and beer, Canadian cannabis company Cronos Group has teamed with synthetic biology firm Ginkgo Bioworks to try and develop better ways of producin...

Ideas, conversations, and resident creativity: An interview with Ginkgo Bioworks’ Christina Agapakis

The post Ideas, conversations, and resident creativity: An interview with Ginkgo Bioworks’ Christina Agapakis appeared first on SynBioBeta.

Cronos Group and Ginkgo Bioworks Announce a Landmark Partnership to Produce Cultured Cannabinoids

The post Cronos Group and Ginkgo Bioworks Announce a Landmark Partnership to Produce Cultured Cannabinoids appeared first on SynBioBeta.

Ginkgo Bioworks Announces Biosecurity Initiative, Using Deep Learning to Reduce the Global Threat of Biological Weapons and Infectious Disease

The post Ginkgo Bioworks Announces Biosecurity Initiative, Using Deep Learning to Reduce the Global Threat of Biological Weapons and Infectious Disease appeared first on SynBioBeta.

Cronos Group's (CRON) Announces Partnership With Ginkgo Bioworks (Conference Call) - Slideshow

PubMed Articles [34 Associated PubMed Articles listed on BioPortfolio]

Land pavement depresses photosynthesis in urban trees especially under drought stress.

Investigations into the photosynthetic response of urban trees on paved land under drought stress would help to improve the management of trees under rapid urbanization and climate change. An experime...

Interrogation of Spatial Metabolome of Ginkgo biloba with High-resolution MALDI and LDI Mass Spectrometry Imaging.

Ginkgo biloba is one of the oldest extant seed plants and has a number of unique properties and uses. Numerous efforts have characterized metabolites within the ginkgo plant and their corresponding bi...

Effects of Ginkgo leaf tablets on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism.

Ginkgo leaf tablets (GLTs) and losartan are often simultaneously used for the treatment of hypertension in Chinese clinics. However, the herb-drug interaction between GLT and losartan is still unknown...

Effect of Ginkgo biloba extract-761 on motor functions in permanent middle cerebral artery occlusion rats.

Ginkgo biloba extract (EGb-761) has been in use to treat variety of ailments including memory loss and emotional disorders usually experienced after ischemic stroke. However, data regarding its protec...

Two new phenolic glycosides isolated from Ginkgo seeds.

Two new phenolic glycosides, 7S, 8R-urolignoside-9'-O-β-D-glucoside (1) and scrophenoside G (2), were isolated and identified from the seeds of Ginkgo biloba L., a famous traditional medicine and fun...

Clinical Trials [28 Associated Clinical Trials listed on BioPortfolio]

A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease

The purpose of this study is to develop procedures for testing the effectiveness of curcumin on slowing Alzheimer's disease (AD) progression.

Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction

The purpose of this study is to provide the first empirical examination of the effects of Ginkgo biloba (GBE), sex therapy, and a combination of the two on subjective and physiological mea...

Ginkgo Biloba Prevention Trial in Older Individuals

This study will determine the effect of 240mg/day Ginkgo biloba in decreasing the incidence of dementia and specifically Alzheimer's disease (AD), slowing cognitive decline and functional ...

Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis

The purpose of this study is to see if treatment with Ginkgo improves cognitive function in people with multiple sclerosis who have cognitive problems.

Clinical Study on Improving the Cognitive Function of Patients With Mild to Moderate Alzheimer's Disease by Using Ginkgo Biloba Dispersible Tablets

This project explores Ginkgo biloba ester dispersible tablets influence on cognitive function in patients with mild-to-moderate elderly, to observe the effects of different intervention ti...

Companies [14 Associated Companies listed on BioPortfolio]

Ginkgo Bioworks

Ginkgo Bioworks is an organism design company that is building organisms to spec for customers across markets including nutrition, health and consumer goods. The company’s or...

Berkeley BioWorks, Inc

Berkeley BioWorks is an engineering consultancy that specializes in the following key services.Whatever the scale of the project, Berkeley BioWorks turns ideas into robust solutions, on time and on bu...

China YCT International Group, Inc.

Established in 2005, China YCT International Group, Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd., a corporation organized under the laws of the People's Republic...

Memphis Bioworks Foundation

The Memphis Bioworks Foundation, a not-for-profit organization, was formed to lead the collaboration among public, private, academic, and government entities to accelerate the gro...

China YCT International Group Inc.

Established in 2005, China YCT International Group Inc., through its operating subsidiary, Shandong Spring Pharmaceutical Co. Ltd. ("Shandong Spring Pharmaceutical"), a corporation organized under...

More Information about "Ginkgo Bioworks" on BioPortfolio

We have published hundreds of Ginkgo Bioworks news stories on BioPortfolio along with dozens of Ginkgo Bioworks Clinical Trials and PubMed Articles about Ginkgo Bioworks for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ginkgo Bioworks Companies in our database. You can also find out about relevant Ginkgo Bioworks Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...


Corporate Database Quicklinks



Searches Linking to this Company Record